ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 18, 2019 | $450,000 | Replaced |
| 3rd Quarter - Amendment | Oct 20, 2019 | $450,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
FDA Patent Settlement legislation Intellectual property and patent issues S. 340, H.R. 965 CREATES Act S. 1209, REMEDY Act S. 1224, H.R. 2374, Stop STALLING Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | — |
| HELEN DWIGHT | — |
| JULIE GARNER | — |
| NATALIE MORRIS | — |
Health Issues HCR
Value of Prescription Drugs Drug Pricing Transparency Oncology Care Model Personalized Medicine Diagnostics S. 1895, Lower Health Care Costs Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | — |
| HELEN DWIGHT | — |
| JULIE GARNER | — |
| NATALIE MORRIS | — |
Medicare/Medicaid MMM
Medicare Part D Coverage and Reimbursement Medicare Part D Non-Interference Legislative proposals to change Medicare Part D Medicare Part B coverage and reimbursement Changes to the Medicaid Drug Rebate Program (AMP Cap) Medicare Part B Intl. Pricing Index ANPRM 14 Day Rule End State Renal Disease PPS
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | . |
| HELEN DWIGHT | — |
| JULIE GARNER | — |
| NATALIE MORRIS | — |
Pharmacy PHA
Medicare Part D coverage and reimbursement Value of Prescription Drugs Prescription Drug Importation Innovative Payment Models Price Transparency Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint H.R. 1499, Protecting Consumer Access to Generic Drugs Act S. 1416, Affordable prescriptions for Patients Act S. 64, H.R. 2375, Preserve Access to Affordable Generics and Biosimilars Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | — |
| HELEN DWIGHT | — |
| JULIE GARNER | — |
| NATALIE MORRIS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.